Measles and rubella virus vaccine - Mitsubishi TanabeAlternative Names: Mearubik
Latest Information Update: 09 Nov 2011
At a glance
- Originator BIKEN
- Developer Mitsubishi Tanabe Pharma Corporation
- Class Measles vaccines; Rubella vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Measles; Rubella
Most Recent Events
- 01 Dec 2005 Launched for Rubella in Japan (IM)
- 01 Dec 2005 Launched for Measles in Japan (IM)